Articles by Daniel Marsh
FTSE 250 Suffers Steepest Drop Since March as Rate Fears Bite
The FTSE 250 dropped 1.67% on Tuesday, its steepest loss since March, as rising bond yields and weak mortgage approvals intensified rate-hike expectations.
Top 1-Year CD Yields 4.35% APY, Outpacing National Average by 2.64 Points
Top one-year CD yields 4.35% APY, beating the 1.71% national average by 2.64 points. A $10,000 deposit earns $435 vs $171, highlighting the value of shopping for rates.
Sonos Shares Dip 1.5% as Ultra Line Tests Premium Pricing Strategy
Sonos shares slipped 1.5% after unveiling its Ultra lineup, priced 50%+ above standard models, as investors question demand for premium audio gear.
Novartis Jumps 6% on Remibrutinib Data as Patent Cliff Looms
Novartis ADRs jumped 6% after remibrutinib met Phase III endpoints in multiple sclerosis, easing concerns about patent expirations. Stock hit $161.22.
KDP's Chobani Exit Yields $925M to Offset Debt
Keurig Dr Pepper's sale of its Chobani stake and Pennsylvania plant will generate $925 million, surpassing its 2026 note maturities and supporting debt reduction.
Alumis Stock Craters 59% on Failed Lupus Trial
Alumis shares dropped 59% after its key lupus trial failed to meet primary and secondary endpoints, erasing $1.67 billion in market value.
Nokia ADRs Drop 2.9% as AI Order Backlog Faces Profitability Test
Nokia ADRs slid 2.9% to $9.845 as investors weigh the company's €2.8B AI order backlog against negative cash flow and restructuring costs.
Fervo Energy Surges 24% on Landmark Google Geothermal Deal
Fervo Energy shares soared 24% after securing a major geothermal power purchase agreement with Google, lifting its market value by $1.1 billion.
bioAffinity Soars 45% on CyPath Surveillance Potential
bioAffinity shares jumped 45% after proposing CyPath Lung for cancer surveillance, with volume 56x shares outstanding.


